Source of funding and disclaimer
The Ruyan® e-cigarettes and the funds for testing them were supplied under a contract by
Ruyan (Holdings) Ltd Hong Kong, but the findings are those of the author. Neither the
author nor Health New Zealand Ltd holds stock in Ruyan (Holdings) Co. Ltd.
Summary
Aim. This report aims to assist regulators in initial assessment of the safety of the
Ruyan® e-cigarette and its cartridges, and the possible risks and benefits from permitting
its use.
Method.
Health New Zealand Ltd contracted with seven leading government, university
and commercial laboratories in New Zealand and Canada to independently perform
various tests on the Ruyan cigarette’s nicotine refill cartridge.
Findings. Ruyan® e-cigarette is designed to be a safe alternative to smoking. The various
test results confirm this is the case. It is very safe relative to cigarettes, and also safe in
absolute terms on all measurements we have applied. Using micro-electronics it
vaporizes, separately for each puff, very small quantities of nicotine dissolved in
propylene glycol, two small well-known molecules with excellent safety profiles, – into a
fine aerosol. Each puff contains one third to one half the nicotine in a
tobacco cigarette’s
puff. The cartridge liquid is
tobacco-free and no combustion occurs.
Competency. The author has authored or co-authored over 30 research papers and
reports in national and international scientific medical journals since 1995, on smoking,
and latterly on testing of cigarettes and cigarette substitutes.
Dr. Murray Laugesen's Publications
Financial disclosure. This report is funded by Ruyan.
Disclaimer. Apart from research Health New Zealand derives no financial benefit from
Ruyan.